BIOMAT Database Logo BIOMAT Database Logo

Serum and bronchoalveolar lavage fluid nitric oxide levels in diffuse systemic sclerosis. 2009

Vedat Inal, and Kenan Aksu, and Gursel Cok, and Ferhan Girgin, and Gokhan Keser, and Fatma Kutay, and Eker Doganavsargil

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D001992 Bronchoalveolar Lavage Fluid Washing liquid obtained from irrigation of the lung, including the BRONCHI and the PULMONARY ALVEOLI. It is generally used to assess biochemical, inflammatory, or infection status of the lung. Alveolar Lavage Fluid,Bronchial Lavage Fluid,Lung Lavage Fluid,Bronchial Alveolar Lavage Fluid,Lavage Fluid, Bronchial,Lavage Fluid, Lung,Pulmonary Lavage Fluid,Alveolar Lavage Fluids,Bronchial Lavage Fluids,Bronchoalveolar Lavage Fluids,Lavage Fluid, Alveolar,Lavage Fluid, Bronchoalveolar,Lavage Fluid, Pulmonary,Lavage Fluids, Alveolar,Lavage Fluids, Bronchial,Lavage Fluids, Bronchoalveolar,Lavage Fluids, Lung,Lavage Fluids, Pulmonary,Lung Lavage Fluids,Pulmonary Lavage Fluids
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D016022 Case-Control Studies Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time. Case-Base Studies,Case-Comparison Studies,Case-Referent Studies,Matched Case-Control Studies,Nested Case-Control Studies,Case Control Studies,Case-Compeer Studies,Case-Referrent Studies,Case Base Studies,Case Comparison Studies,Case Control Study,Case Referent Studies,Case Referrent Studies,Case-Comparison Study,Case-Control Studies, Matched,Case-Control Studies, Nested,Case-Control Study,Case-Control Study, Matched,Case-Control Study, Nested,Case-Referent Study,Case-Referrent Study,Matched Case Control Studies,Matched Case-Control Study,Nested Case Control Studies,Nested Case-Control Study,Studies, Case Control,Studies, Case-Base,Studies, Case-Comparison,Studies, Case-Compeer,Studies, Case-Control,Studies, Case-Referent,Studies, Case-Referrent,Studies, Matched Case-Control,Studies, Nested Case-Control,Study, Case Control,Study, Case-Comparison,Study, Case-Control,Study, Case-Referent,Study, Case-Referrent,Study, Matched Case-Control,Study, Nested Case-Control
D045743 Scleroderma, Diffuse A rapid onset form of SYSTEMIC SCLERODERMA with progressive widespread SKIN thickening over the arms, the legs and the trunk, resulting in stiffness and disability. Diffuse Cutaneous Systemic Sclerosis,Diffuse Scleroderma,Diffuse Systemic Sclerosis,Scleroderma, Progressive,Sclerosis, Progressive Systemic,Sudden Onset Scleroderma,Diffuse Systemic Scleroses,Progressive Scleroderma,Progressive Systemic Sclerosis,Scleroderma, Sudden Onset,Sclerodermas, Sudden Onset,Scleroses, Diffuse Systemic,Sclerosis, Diffuse Systemic,Sudden Onset Sclerodermas,Systemic Scleroses, Diffuse,Systemic Sclerosis, Diffuse,Systemic Sclerosis, Progressive

Related Publications

Vedat Inal, and Kenan Aksu, and Gursel Cok, and Ferhan Girgin, and Gokhan Keser, and Fatma Kutay, and Eker Doganavsargil
Cotinine levels in serum and bronchoalveolar lavage fluid.
September 2010, The Southeast Asian journal of tropical medicine and public health,
Vedat Inal, and Kenan Aksu, and Gursel Cok, and Ferhan Girgin, and Gokhan Keser, and Fatma Kutay, and Eker Doganavsargil
CXCL11 in bronchoalveolar lavage fluid and pulmonary function decline in systemic sclerosis.
January 2012, Clinical and experimental rheumatology,
Vedat Inal, and Kenan Aksu, and Gursel Cok, and Ferhan Girgin, and Gokhan Keser, and Fatma Kutay, and Eker Doganavsargil
Cytokine concentrations in bronchoalveolar lavage fluid of patients with systemic sclerosis.
April 1997, Arthritis and rheumatism,
Vedat Inal, and Kenan Aksu, and Gursel Cok, and Ferhan Girgin, and Gokhan Keser, and Fatma Kutay, and Eker Doganavsargil
Neutrophilia in bronchoalveolar lavage fluid of diffuse panbronchiolitis.
October 1990, Chest,
Vedat Inal, and Kenan Aksu, and Gursel Cok, and Ferhan Girgin, and Gokhan Keser, and Fatma Kutay, and Eker Doganavsargil
Nitric oxide derivative in bronchoalveolar lavage fluid from patients with idiopathic pulmonary fibrosis.
January 2002, The Indian journal of chest diseases & allied sciences,
Vedat Inal, and Kenan Aksu, and Gursel Cok, and Ferhan Girgin, and Gokhan Keser, and Fatma Kutay, and Eker Doganavsargil
[Changes in lymphocyte subsets in bronchoalveolar lavage fluid in patients with systemic sclerosis].
January 2000, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego,
Vedat Inal, and Kenan Aksu, and Gursel Cok, and Ferhan Girgin, and Gokhan Keser, and Fatma Kutay, and Eker Doganavsargil
[Serum and bronchoalveolar lavage fluid neopterin levels in patients with bronchial asthma].
January 2003, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego,
Vedat Inal, and Kenan Aksu, and Gursel Cok, and Ferhan Girgin, and Gokhan Keser, and Fatma Kutay, and Eker Doganavsargil
Proteome analysis of bronchoalveolar lavage fluid in lung fibrosis associated with systemic sclerosis.
December 2010, Allergology international : official journal of the Japanese Society of Allergology,
Vedat Inal, and Kenan Aksu, and Gursel Cok, and Ferhan Girgin, and Gokhan Keser, and Fatma Kutay, and Eker Doganavsargil
Diffuse alveolar damage. Morphologic features in bronchoalveolar lavage fluid.
January 2000, Acta cytologica,
Vedat Inal, and Kenan Aksu, and Gursel Cok, and Ferhan Girgin, and Gokhan Keser, and Fatma Kutay, and Eker Doganavsargil
Enzyme levels in bronchoalveolar lavage fluid and serum of active pulmonary tuberculosis patients.
January 1989, Enzyme,
Copied contents to your clipboard!